Blood light therapy tested for debilitating cancer treatment side effect
NCT ID NCT06646016
Summary
This study aimed to test if a blood treatment called extracorporeal photopheresis (ECP) could help patients with melanoma or lung cancer who developed severe colon inflammation from their cancer immunotherapy. The inflammation did not improve with standard steroid treatment. Researchers planned to compare ECP against other available therapies to see which was better at controlling this painful and dangerous side effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE-RELATED COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.